[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336871-105":59,"doc-detail-336871-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-novel-prognostic-model-of-hepatocellular-carcinoma-per-two-nad-metabolic-synthesis-associated-genes-abstract","A Novel Prognostic Model of Hepatocellular Carcinoma per Two NAD+ Metabolic Synthesis-Associated Genes - Abstract","","Hepatocellular carcinoma (HCC) remains a major global health challenge, and the prognostic relevance of NAD+ signaling is not fully clarified. Gene expression and corresponding clinical pathological datasets for HCC were collected from TCGA, with NAD+-related genes retrieved from GSEA and evaluated through differential analyses in tumor versus normal tissues. Consensus clustering defined four patient groups, followed by Kaplan–Meier survival comparisons. A two-gene NAD+-associated signature (PARP2 and SIRT6) was derived using LASSO-Cox regression and validated by uni- and multivariate Cox models and ROC analyses, with immunohistochemistry, qRT-PCR, and Western blotting confirming higher expression in HCC.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-novel-prognostic-model-of-hepatocellular-carcinoma-per-two-nad-metabolic-synthesis-associated-genes-abstract/336871/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-novel-prognostic-model-of-hepatocellular-carcinoma-per-two-nad-metabolic-synthesis-associated-genes-abstract/336871.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What data sources and analysis strategy were used to build the NAD+-related prognostic model?","Question",{"text":113,"@type":114},"The study used gene expression files and clinical pathological files from TCGA and retrieved NAD+-associated genes from GSEA. Differential analyses compared tumor and normal tissues, followed by consensus clustering and survival assessment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which two genes form the novel prognostic signature for HCC?",{"text":118,"@type":114},"The two-gene signature consists of PARP2 and SIRT6. It was obtained through LASSO-Cox regression and showed favorable prognostic performance in TCGA-based HCC patients.",{"name":120,"@type":111,"acceptedAnswer":121},"How was the prognostic model validated and what statistical methods supported its performance?",{"text":122,"@type":114},"The model was assessed with LASSO-Cox regression plus uni- and multivariate Cox regression, and ROC curve analyses. The nomogram also demonstrated clinical significance for HCC patient prognosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},336871,1790681814,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Article  \nA Novel Prognostic Model of Hepatocellular Carcinoma per Two NAD+ Metabolic Synthesis-Associated Genes  \nLuo Dai 1,2,3,†, Shiliu Lu 1,2,3,†, Linfeng Mao 1,2, Mingbei Zhong 1,2,3, Gangping Feng 1,2,3, Songqing He 1,2,3, * and Guandou Yuan 1,2,3, *  \nCitation: Dai, L.; Lu, S.; Mao, L.; Zhong, M.; Feng, G.; He, S.; Yuan, G. A Novel Prognostic Model of Hepatocellular Carcinoma per Two NAD+ Metabolic Synthesis-Associated Genes. Int. J. Mol. Sci. 2024, 25, 10362 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms251910362  \nAcademic Editor: Walter Wahli  \nReceived: 19 August 2024  \nRevised: 14 September 2024  \nAccepted: 16 September 2024  \nPublished: 26 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Division of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China; [dl_dailuo@163.com](dl_dailuo@163.com) (L.D.); [shiliulu@126.com](shiliulu@126.com) (S.L.); [gxmumlf@163.com](gxmumlf@163.com) (L.M.); [18277640805@163.com](18277640805@163.com) (M.Z.); [gangpingfeng@163.com](gangpingfeng@163.com) (G.F.)  \n2 Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning 530021, China  \n3 Guangxi Key Laboratory of Immunology and Metabolism for Liver Diseases, Nanning 530021, China  \n* [Correspondence: hesongqing@tjh.tjmu.edu.cn](Correspondence: hesongqing@tjh.tjmu.edu.cn) (S.H.); [dr_yuangd@gxmu.edu.cn](dr_yuangd@gxmu.edu.cn) (G.Y.)† These authors contributed equally to this work.  \nAbstract: Hepatocellular carcinoma (HCC) is a formidable challenge to global human health, while recent years have witnessed the important role of NAD+ in tumorigenesis and progression. However, the expression pattern and prognostic value of NAD+ in HCC still remain elusive. Gene expression files and corresponding clinical pathological files associated with HCC were obtained from the Cancer Genome Atlas (TCGA) database, and genes associated with NAD+ were retrieved from the GSEA and differentially analyzed in tumor and normal tissues. A consensus clustering analysis was conducted by breaking down TCGA patients into four distinct groups, while Kaplan–Meier curves were generated to investigate the disparity in clinical pathology and endurance between clusters. A prognostic model based on NAD+-associated genes was established and assessed by combining LASSO-Cox regression, uni-and multi-variate Cox regression, and ROC curve analyses. Investigations were conducted to determine the expression of distinct mRNAs and proteins in both HCC and non-tumor tissues. A novel two-gene signature including poly (ADP-Ribose) polymerase 2 (PARP2) and sirtuin 6 (SIRT6) was obtained through LASSO-Cox regression and was identified to have favorable prognostic performance in HCC patients from TCGA. Analyses of both single and multiple variables showed that the prognostic model was a distinct prognostic factor in the endurance of liver cancer patients in both the training and trial groups. The nomogram also exhibited clinical significance in the prognosis of HCC patients. Immunohistochemistry, qRT-PCR, and Western blotting revealed that HCC samples exhibited higher PARP2 and SIRT6 expression levels than those of normal controls. This study identified a robust prognostic model comprising two NAD+-associated genes using bioinformatic methods, which is accurate in predicting the survival outcome of HCC patients. This model might benefit the early diagnosis of HCC and further facilitate the management of individualized medical service and clinical decision-making.  \nKeywords: hepatocellul","cbCaikVppFiergvx","https://ap.wps.com/l/cbCaikVppFiergvx","pdf",9390362,12,"English","# Abstract\n## Bioinformatic analysis and clustering\n## Prognostic model construction and validation\n## Two-gene signature discovery\n## Experimental validation in HCC tissues","[{\"question\":\"What data sources and analysis strategy were used to build the NAD+-related prognostic model?\",\"answer\":\"The study used gene expression files and clinical pathological files from TCGA and retrieved NAD+-associated genes from GSEA. Differential analyses compared tumor and normal tissues, followed by consensus clustering and survival assessment.\"},{\"question\":\"Which two genes form the novel prognostic signature for HCC?\",\"answer\":\"The two-gene signature consists of PARP2 and SIRT6. It was obtained through LASSO-Cox regression and showed favorable prognostic performance in TCGA-based HCC patients.\"},{\"question\":\"How was the prognostic model validated and what statistical methods supported its performance?\",\"answer\":\"The model was assessed with LASSO-Cox regression plus uni- and multivariate Cox regression, and ROC curve analyses. The nomogram also demonstrated clinical significance for HCC patient prognosis.\"}]","A Novel Prognostic Model of Hepatocellular Carcinoma per Two NAD+ Metabolic Synthesis-Associated Genes - Abstract | PDF",1790016921,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/094d957d14dee5918b8974cd9bd06d67.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e47d35e1c994ff4e14f36ceeade64c8d.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb46d9b55e76d818860f4828308372b2.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ed3a51626842d4094494c0300570013.webp",980,1385]